Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays

Journal of Clinical Microbiology

Volumn 37, Issue 8, 1999, Pages 2525-2532

  Mellor, Janet ^a   Hawkins, Anna ^a   Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; IN SITU HYBRIDIZATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; REFERENCE VALUE; VIRUS LOAD;

CHIRON; HEPATITIS C VIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0032773440     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.8.2525-2532.1999     Document Type: Article

References (20)

1. Berger, A., M. von Depka Prondzinski, H. W. Doerr, H. Rabenau, and B. Weber. 1996. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J. Med. Virol. 48:339-343.
2. Chan, C. Y., S. D. Lee, S. J. Hwang, R. H. Lu, C. L. Lu, and K. J. Lo. 1995. Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C. J. Infect. Dis. 171: 443-446.
3. Chan, S.-W., F. McOmish, E. C. Holmes, B. Dow, J. F. Peutherer, E. Follett, P. L. Yap, and P. Simmonds. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1131-1141.
4. Collins, M. L., C. Zayati, J. J. Detmer, B. Daly, J. A. Kolberg, T. A. Cha, B. D. Irvine, J. Tucker, and M. S. Urdea. 1995. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal. Biochem. 226:120-129.
5. Craxi, J., S. Magrin, C. Fabiano, C. Linea, and P. Almasio. 1995. Host and viral features in chromic HCV infection: relevance to interferon responsiveness. Res. Virol. 146:273-278.
6. Daly, J. A., and G. Ertingshausen. 1972. Direct method for determining inorganic phosphate in serum with the "CentrifiChem." Clin. Chem. 18:263-265.
7. Detmer, J., R. Lagier, J. Flynn, C. Zayati, J. Kolberg, M. Collins, M. Urdea, and R. Sanchez-Pescador. 1996. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 34:901-907.
8. Hawkins, A., F. Davidson, and P. Simmonds. 1997. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J. Clin. Microbiol. 35:187-192.
9. Lau, J. Y. N., P. Simmonds, and M. S. Urdea. 1995. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 346:425-426.
10. Lu, R. H., S. J. Hwang, C. Y. Chan, F. Y. Chang, and S. D. Lee. 1998. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV Monitor system and branched DNA signal amplification assay. J. Clin. Lab. Anal. 12:121-125.
11. Mahaney, K., V. Tedeschi, G. Maertens, A. M. Dibisceglie, J. Vergalla, J. H. Hoofhagle, and R. Sallie. 1994. Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405-1411.
12. Martinot Peignoux, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquin, C. Degott, I. Descombes, V. Lebreton, V. Milotova, J. P. Benhamou, and S. Erlinger. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
13. Matsumoto, A., E. Tanaka, T. Suzuki, H. Ogata, and K. Kiyosawa. 1994. Viral and host factors that contribute to efficacy of interferon-alpha(2a) therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 39:1273-1280.
14. Orito, E., M. Mizokami, T. Nakano, H. Terashima, O. Nojiri, H. Sakakibara, M. Mizuno, M. Ogino, M. Nakamura, Y. Matsumoto, K. I. Miyata, and J. Y. N. Lan. 1994. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C. J. Med. Virol. 44:410-414.
15. Simmonds, P., P. Balfe, J. F. Peutherer, C. A. Ludlam, J. O. Bishop, and A. J. Brown. 1990. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64:864-872.
16. Smith, D. B., F. Davidson, P. L. Yap, H. Brown, J. Kolberg, J. Detmer, M. Urdea, P. Simmonds, J. Mellor, J. Neville, L. Prescott, B. C. Dow, E. A. C. Follett, T. Skuldamrongpanich, S. Tanprasert, C. Nuchaprayoon, C. K. Lin, M. C. Kew, R. Crookes, J. D. Conradie, M. Lin, C. Seed, G. A. B. Deolim, I. A. Martins, G. A. Medgyesi, T. Krusius, A. A. Saeed, D. Teo, and S. H. Lee. 1996. Levels of hepatitis C virus in blood donors infected with different viral genotypes. J. Infect. Dis. 173:727-730.
17. Warshaw, M. M., and I. Tinico. 1966. Optical properties of sixteen dinucleoside phosphates. J. Mol. Biol. 20:29-38.
18. Yamada, G., R. Takatani, F. Kishi, M. Takahashi, T. Doi, T. Tsuji, S. Shin, M. Tanno, M. S. Urdea, and J. A. Kolberg. 1995. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 22:1351-1354.
19. Zein, N. N., J. Rakela, and D. H. Persing. 1995. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin. Proc. 70:449-452.
20. Zhang, L. Q., P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown. 1991. Detection, quantitation and sequencing of HIV-1 virus from the plasma of seropositive individuals and from factor VIII concentrates. AIDS 5:675-681.